PHARMA TECHNOLOGIES LIMITED, Manchester, Vereinigtes Königreich

Aktionäre

Name	Beteiligung	Stimmrecht	Seit

Wirtschaftlich Berechtigter

Name	Beteiligung	Land	Seit

Finanzen

Kennzahlen aus Jahresabschlüssen.

Umrechnen in

2016

Gewinn / (Verlust): £-17

Kennzahlen

Gewinn / (Verlust)

2016£-17

2017£3.604

2018—

2019—

Gesamtvermögen

2016£100

2017£100

2018£100

2019£100

Equity

2016—

2017£100

2018£100

2019£100

Current Assets

2016£2.033

2017£2.033

2018£6.492

2019£1.131

Net Current Assets Liabilities

2016£83

2017£83

2018£3.687

2019£-69

Total Assets Less Current Liabilities

2016£83

2017—

2018—

2019—

Cash Bank On Hand

2016—

2017£1.933

2018£6.392

2019£176

Debtors

2016£100

2017£100

2018£100

2019£955

Other Debtors

2016—

2017£100

2018£100

2019£100

Creditors

2016—

2017£1.950

2018£2.805

2019£1.200

Other Creditors

2016—

2017£1.950

2018£1.950

2019£1.200

Issue Equity Instruments

2016£100

2017£100

2018—

2019—

Number Shares Allotted

2016100

2017—

2018—

2019—

Number Shares Issued Fully Paid

2016—

2017100

2018100

2019100

Par Value Share

2016£1

2017£1

2018£1

2019£1

Called Up Share Capital

2016£100

2017—

2018—

2019—

Cash Bank In Hand

2016£1.933

2017—

2018—

2019—

Corporation Tax Payable

2016—

2017£855

2018£855

2019—

Corporation Tax Recoverable

2016—

2017—

2018£855

2019£855

Creditors Due Within One Year

2016£1.950

2017—

2018—

2019—

Net Assets Liabilities Including Pension Asset Liability

2016£83

2017—

2018—

2019—

Profit Loss Account Reserve

2016£-17

2017—

2018—

2019—

Share Capital Allotted Called Up Paid

2016£100

2017—

2018—

2019—

Shareholder Funds

2016£83

2017—

2018—

2019—

Kennzahl	2016	2017	2018	2019
Gewinn / (Verlust)	£-17	£3.604	—	—
Gesamtvermögen	£100	£100	£100	£100
Equity	—	£100	£100	£100
Current Assets	£2.033	£2.033	£6.492	£1.131
Net Current Assets Liabilities	£83	£83	£3.687	£-69
Total Assets Less Current Liabilities	£83	—	—	—
Cash Bank On Hand	—	£1.933	£6.392	£176
Debtors	£100	£100	£100	£955
Other Debtors	—	£100	£100	£100
Creditors	—	£1.950	£2.805	£1.200
Other Creditors	—	£1.950	£1.950	£1.200
Issue Equity Instruments	£100	£100	—	—
Number Shares Allotted	100	—	—	—
Number Shares Issued Fully Paid	—	100	100	100
Par Value Share	£1	£1	£1	£1
Called Up Share Capital	£100	—	—	—
Cash Bank In Hand	£1.933	—	—	—
Corporation Tax Payable	—	£855	£855	—
Corporation Tax Recoverable	—	—	£855	£855
Creditors Due Within One Year	£1.950	—	—	—
Net Assets Liabilities Including Pension Asset Liability	£83	—	—	—
Profit Loss Account Reserve	£-17	—	—	—
Share Capital Allotted Called Up Paid	£100	—	—	—
Shareholder Funds	£83	—	—	—

PHARMA TECHNOLOGIES LIMITED

Zusammenfassung

Recht & Status

Timeline (13 Ereignisse)

Adresse aktualisiert

Jahresabschluss eingereicht

Bestellt Andrew Paul Green (Person)

Netzwerk

Eigentum & Führung

Persons with significant control

Officers & directors

Eigentümer-Timeline (2 Änderungen)

Bestellt Andrew Paul Green (Person)

Bestellt David Richard Sharples (Person)

Aktionäre

Wirtschaftlich Berechtigter

Geografie

Finanzen

Kennzahlen

Dokumente

Unternehmensbericht von PHARMA TECHNOLOGIES LIMITED

Final Gazette dissolved via voluntary strike-off

First Gazette notice for voluntary strike-off

Strike off from register

Total exemption full accounts made up to 31 December 2019

Companexia Document AI

Confirmation statement

Annual Accounts

Total exemption full accounts made up to 31 December 2018

Change of director details

Confirmation statement

Weitere Unternehmen & Personen durchsuchen

Finanzielle Kennzahlen

Wachstum

Effizienz & Rendite

Working Capital & Liquidität

Kapitalstruktur